These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30043122)

  • 1. Development of an Algorithm to Identify Cannabis Urine Drug Test Results within a Multi-Site Electronic Health Record System.
    Morasco BJ; Shull SE; Adams MH; Dobscha SK; Lovejoy TI
    J Med Syst; 2018 Jul; 42(9):163. PubMed ID: 30043122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care.
    Zaman T; Bravata DM; Byers AL; Krebs EE; Leonard SJ; Sandbrink F; Barker W; Keyhani S
    BMC Psychiatry; 2023 Mar; 23(1):177. PubMed ID: 36927526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
    Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
    Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine drug testing: current recommendations and best practices.
    Owen GT; Burton AW; Schade CM; Passik S
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.
    Andraka-Christou B; McAvoy E; Gordon AJ; Ohama M; Brach M; Taylor EA; Vaiana M; Saloner B; Stein BD
    Pain Med; 2023 Dec; 24(12):1306-1317. PubMed ID: 37551941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
    Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
    J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random urine drug testing among patients receiving opioid therapy for cancer pain.
    Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E
    Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
    Matteliano D; Chang YP
    Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of microscopic hematuria detected by urine dipstick test in the evaluation of patients with renal colic.
    Argyropoulos A; Farmakis A; Doumas K; Lykourinas M
    Urol Res; 2004 Aug; 32(4):294-7. PubMed ID: 15045479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine drug test interpretation: what do physicians know?
    Reisfield GM; Bertholf R; Barkin RL; Webb F; Wilson G
    J Opioid Manag; 2007; 3(2):80-6. PubMed ID: 17520987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects.
    Lee CT; Vo TT; Cohen AS; Ahmed S; Zhang Y; Mao J; Chen L
    Pain Med; 2016 Apr; 17(4):636-43. PubMed ID: 26398237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated Quantitative Urine Toxicology Analysis May Improve Chronic Pain Patient Compliance with Opioid Therapy.
    Knezevic NN; Khan OM; Beiranvand A; Candido KD
    Pain Physician; 2017 Feb; 20(2S):S135-S145. PubMed ID: 28226335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.